FMP
NASDAQ
7.05 USD
0.01 (0.142%)
Dr. Markus Warmuth M.D.
Healthcare
Biotechnology
https://www.monterosatx.com
NASDAQ
Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing protein for the treatment of Myc-driven cancers. The company also develops CDK2 to treat ovarian, uterine, and breast cancers; NEK7 for the treatment of inflammatory diseases, such as Crohn's disease, neurodegenerative disease, diabetes, and liver disease; VAV1, a target protein for autoimmune diseases; and BCL11A, a therapeutically-relevant protein in he...
0001826457
US61225M1027
61225M102
645 Summer Street
617 949 2643
US
133
Jun 24, 2021
0001826457
NASDAQ
Biotechnology
Healthcare
61225M102
US61225M1027
US
7.05
1.42
153.63k
353.59M
-
2.44-8.84
1.6
-
-
-
-
-2.68
-
https://www.monterosatx.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.